{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:15:22Z","timestamp":1787508922680,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020656","name":"The Conny-Maeva Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005630","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.rpth.2025.102969","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:42:21Z","timestamp":1752626541000},"page":"102969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Geoffrey","family":"Foulon-Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Jourdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Delrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Lafuente-Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Cavalie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gouin-Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Gaussem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Mirault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Puymirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lecompte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pautas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Curis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6509-8964","authenticated-orcid":false,"given":"Virginie","family":"Siguret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102969_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.102969_bib2","article-title":"Prevalence and incidence of atrial fibrillation and other arrhythmias in the general older population: findings from the Swedish national study on aging and care","volume":"5","author":"Lindberg","year":"2019","journal-title":"Gerontol Geriatr Med"},{"key":"10.1016\/j.rpth.2025.102969_bib3","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.102969_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2025.102969_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.114.013267","article-title":"Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis","volume":"132","author":"Sharma","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.102969_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/jcm8040554","article-title":"Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists for people aged 75 years and over with atrial fibrillation: a systematic review and meta-analyses of observational studies","volume":"8","author":"Mitchell","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2025.102969_bib7","first-page":"205","article-title":"Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study","volume":"22","author":"Fauchier","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.rpth.2025.102969_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10557-020-06981-3","article-title":"Anticoagulants for stroke prevention in atrial fibrillation in elderly patients","volume":"34","author":"Sch\u00e4fer","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.rpth.2025.102969_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12603-017-0982-4","article-title":"Real-life peak and trough dabigatran plasma measurements over time in hospitalized geriatric patients with atrial fibrillation","volume":"22","author":"Chaussade","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.rpth.2025.102969_bib10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/jgs.15982","article-title":"Apixaban concentrations with lower than recommended dosing in older adults with atrial fibrillation","volume":"67","author":"Sukumar","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rpth.2025.102969_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40266-018-0613-8","article-title":"Apixaban levels in octogenarian patients with non-valvular atrial fibrillation","volume":"36","author":"Nissan","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rpth.2025.102969_bib12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/jgs.16992","article-title":"Muscle mass and direct oral anticoagulant activity in older adults with atrial fibrillation","volume":"69","author":"Bendayan","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rpth.2025.102969_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/ejhpharm-2020-002456","article-title":"Dabigatran trough concentrations in very elderly patients","volume":"28","author":"Gommans","year":"2021","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.rpth.2025.102969_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thromres.2021.02.034","article-title":"Inappropriate low dosing of direct oral anticoagulants in older patients with non-valvular atrial fibrillation: impact on plasma drug levels","volume":"201","author":"Comans","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102969_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/a-2021-8910","article-title":"Direct oral anticoagulants in the very elderly","volume":"123","author":"Eikelboom","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/a-1981-1763","article-title":"Assessment of DOAC in geriatrics (Adage Study): rivaroxaban\/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients","volume":"123","author":"Foulon-Pinto","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib18","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1182\/bloodadvances.2023012408","article-title":"Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study","volume":"8","author":"Testa","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102969_bib19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/jth.13801","article-title":"Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study","volume":"15","author":"Kreutz","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/rth2.12044","article-title":"Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay","volume":"1","author":"Artang","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s11239-017-1492-2","article-title":"Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement","volume":"43","author":"Helin","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2025.102969_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2018.03.012","article-title":"The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma","volume":"165","author":"Zhang","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102969_bib23","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1177\/1076029618802364","article-title":"Laboratory assessment of the anticoagulant activity of apixaban in patients with nonvalvular atrial fibrillation","volume":"24","author":"Kyriakou","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.102969_bib24","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/ijlh.12767","article-title":"Effect of rivaroxaban on thrombin generation in vivo. A study in obese patients","volume":"40","author":"Bertaggia-Calderara","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.102969_bib25","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jth.14541","article-title":"Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: modeling and assessing interindividual variability","volume":"17","author":"Siguret","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/rth2.12340","article-title":"Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system","volume":"4","author":"Pfrepper","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/rth2.12332","article-title":"Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants","volume":"4","author":"Metze","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/rth2.12497","article-title":"Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram","volume":"5","author":"Helin","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib29","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","article-title":"Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine","volume":"19","author":"Depasse","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib30","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ijlh.13721","article-title":"Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA","volume":"44","author":"Pfrepper","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.102969_bib32","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bpj.2012.10.011","article-title":"Thrombin activity propagates in space during blood coagulation as an excitation wave","volume":"103","author":"Dashkevich","year":"2012","journal-title":"Biophys J"},{"key":"10.1016\/j.rpth.2025.102969_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/09537104.2020.1823360","article-title":"Determination of fibrin clot growth and spatial thrombin propagation in the presence of different types of phospholipid surfaces","volume":"32","author":"Koltsova","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.102969_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MBC.0b013e328352e90e","article-title":"Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics","volume":"23","author":"Soshitova","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2025.102969_bib35","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3109\/10428194.2015.1041385","article-title":"Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma","volume":"56","author":"Gracheva","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.rpth.2025.102969_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41390-018-0184-8","article-title":"Impaired platelet activity and hypercoagulation in healthy term and moderately preterm newborns during the early neonatal period","volume":"85","author":"Koltsova","year":"2019","journal-title":"Pediatr Res"},{"key":"10.1016\/j.rpth.2025.102969_bib37","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.3390\/ijms21249434","article-title":"Accelerated spatial fibrin growth and impaired contraction of blood clots in patients with rheumatoid arthritis","volume":"21","author":"Peshkova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2025.102969_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2020.01.012","article-title":"Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters","volume":"187","author":"Bertaggia Calderara","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102969_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282939","article-title":"Integral assays of hemostasis in hospitalized patients with COVID-19 on admission and during heparin thromboprophylaxis","volume":"18","author":"Bulanov","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.102969_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.talanta.2017.12.055","article-title":"Thrombodynamics, a new global coagulation test: measurement of heparin efficiency","volume":"180","author":"Sinauridze","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.rpth.2025.102969_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1515\/jpm-2016-0333","article-title":"The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery","volume":"46","author":"Koltsova","year":"2018","journal-title":"J Perinat Med"},{"key":"10.1016\/j.rpth.2025.102969_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199900","article-title":"Thrombodynamics-A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment","volume":"13","author":"Balandina","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.102969_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221142862","article-title":"Correction of anticoagulant therapy in patients with severe COVID-19 virus infection using a Thrombodynamics coagulation assay","volume":"28","author":"Vuimo","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.102969_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep29242","article-title":"The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency","volume":"6","author":"Gribkova","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2025.102969_bib45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ijlh.13443","article-title":"Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: analytical performances over 18 months","volume":"43","author":"Foulon-Pinto","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.102969_bib46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.thromres.2013.12.014","article-title":"Effect of pre-analytical conditions on the thrombodynamics assay","volume":"133","author":"Dashkevich","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102969_bib47","series-title":"a language and environment for statistical computing","year":"2023"},{"key":"10.1016\/j.rpth.2025.102969_bib48","series-title":"Python 3 reference manual","author":"Van Rossum","year":"2009"},{"key":"10.1016\/j.rpth.2025.102969_bib49","series-title":"Data structures for statistical computing in Python","first-page":"56","author":"McKinney","year":"2010"},{"key":"10.1016\/j.rpth.2025.102969_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.rpth.2025.102969_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"10.1016\/j.rpth.2025.102969_bib52","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.rpth.2025.102969_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.rpth.2025.102969_bib54","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1538-7836.2010.03822.x","article-title":"The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha-macroglobulin-thrombin","volume":"8","author":"Wagenvoord","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib55","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jth.12591","article-title":"Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo","volume":"12","author":"Perzborn","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102969_bib56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2015.04.032","article-title":"From laboratory to clinical practice: dabigatran effects on thrombin generation and coagulation in patient samples","volume":"136","author":"Helin","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102969_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mad.2015.08.006","article-title":"Primary and secondary haemostasis changes related to aging","volume":"150","author":"Sep\u00falveda","year":"2015","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.rpth.2025.102969_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087692","article-title":"Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients","volume":"9","author":"Lipets","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.102969_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227932","article-title":"Use of Thrombodynamics for revealing the participation of platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation","volume":"15","author":"Lipets","year":"2020","journal-title":"PLoS One"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925002936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925002936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:13:52Z","timestamp":1773843232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925002936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2475037925002936"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102969","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102969"}}